Table I. Characteristics of the Patient and Control Populations.
Patients (n=126) | Controls (n=114) | P value | |
---|---|---|---|
Age | 0.0001 | ||
<18 months | 58 | 0 | |
>18 months | 68 | 114 | |
| |||
Gender | 0.52 | ||
Female | 61 (48%) | 50 (44%) | |
Male | 65 (52%) | 64 (56%) | |
| |||
Ethnicity | 0.3 | ||
Hispanic | 30 (24%) | 31 (27%) | |
NH White | 71 (56%) | 57 (50%) | |
NH Black | 12 (10%) | 16 (14%) | |
Other | 12 (10%) | 10 (9%) | |
| |||
INSS Tumor Stage | |||
Stage 1 | 10 (8%) | ||
Stage 2 | 17 (13%) | ||
Stage 3 | 30 (24%) | ||
Stage 4 | 59 (47%) | ||
Stage 4S | 8 (6%) | ||
Unknown | 2 (2%) | ||
| |||
Risk Group | |||
Low | 22 (18%) | ||
Intermediate | 30 (24%) | ||
High | 61 (48%) | ||
Unknown | 13 (10%) | ||
| |||
MYCN status | |||
Amplified | 35 (28%) | ||
Non-amplified | 67 (53%) | ||
Unknown | 24 (19%) |